Congratulations to Dr Jacob Bush, recipient of the 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship.
The Lectureship was open to any candidate who received their PhD in 2011 or later and has made a significant contribution to medicinal chemistry in their early career. The RSC Medicinal Chemistry Editorial Board selected Dr. Bush, from GSK, from a short-list of nominees.
Many congratulations to Dr. Bush for winning the lectureship.
When he was informed of his selection, Dr. Bush said:
“It’s a privilege to receive this lectureship as it recognises cutting edge work in chemical biology by a team of outstanding scientists both at GSK and at our academic partner institutions. Building these innovative technologies for agile target validation is key to GSK’s differentiated approach to identify, select and develop more genetically validated targets which have higher likelihood of success.”
About Dr Bush:
Dr Jacob Bush works in medicinal chemistry & chemical biology at GSK, leading the development of new technologies to accelerate drug discovery, in particular through innovations in chemical biology and artificial intelligence (AI). He works between GSK, where he is group leader in the chemical biology department and The Francis Crick Institute, where he is an active member of the leadership team of the GSK-Crick LinkLabs collaboration.